查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1425055

BFS 注射器市场 - 预测 2024-2029

BFS Syringe Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2022年BFS注射器市场规模为406,801,000美元。

医疗保健和化妆品行业对 BFS 注射器的需求不断增长，预计将推动市场扩张。推动市场需求的是现代药品包装类型和单位剂量包装的选择。製药公司使用采用吹-灌-封 (BFS) 技术的预填充式注射器。因此，预计 BFS 注射器市场在预测期内将显着成长。无菌包装公司越来越多地在包装和自动化流程中使用一种称为吹灌封 (BFS) 的灭菌技术。 BFS技术已获得FDA（美国食品药物管理局）认证，用于药品和保健品的製造，而改进的无菌加工技术正在为BFS注射器市场的扩大创造有利的市场动态。此外，美容注射器（例如精华液和其他护肤品）的使用也预计将刺激市场需求。

介绍

BFS 技术只需很少的人工即可准备，最近在製药业得到了广泛的应用。包括美国食品药物管理局(FDA) 在内的多个监管机构认为该技术是机密药品无菌填充的首选方法。製药公司考虑了 BFS 注射器的几个优点，包括低营运成本、灵活的包装设计、高无菌性、低劳动力需求和低零件库存。该技术起源于欧洲，那里的需求量很大，其次是北美。这种方法常用于製药业，并且可以使母体製剂的填充受到很少的人为干扰。此外，它也用于填充眼药水、吸入装置、静脉注射液和其他母体製剂。在医疗保健领域，对效率和剂量准确性的重视正在推动注射器技术的进步。自从推出吹灌封 (BFS) 注射器以来，注射器的包装和用途发生了变化。领先的注射器製造商目前正在转向 BFS 技术，该技术已被多个监管机构认可为无菌填充药物的优越技术，从而对市场成长产生积极影响。

促进因素

  • 对无菌填充的需求不断增长正在推动市场成长：随着包装产业自动化的引入，BFS 注射器提供了无菌解决方案并满足了对无菌条件的需求。使用 BFS 注射器技术的无菌包装可在每分钟包装的清洁物品数量方面提供高精度，最终促进市场成长。
  • 医药产业的成长正在推动市场需求：医药产业的快速成长正在推动市场的成长。领先的药品製造商利用最先进的灭菌工艺来最大限度地减少包装液体药品时操作员的互动和污染的可能性。
  • 降低 BFS 注射器污染的可能性并创造市场需求：利用自动化 BFS 技术，注射器的製造、填充和密封一步完成。因此，污染的可能性较小，并且被医疗保健专业人员广泛接受。
  • 这些注射器不需要冷藏储存，导致价格较低：BFS注射器通常用于呼吸、眼科、口服、预填充式注射器和注射药物的无菌包装。这些产品对消费者来说很方便，对供应商来说也很经济，因为它们不需要冷藏。
  • 新兴经济体对疫苗的需求不断增长：新兴经济体对疫苗的需求激增是市场开拓的主要因素。随着印度等国家疫苗接种率的提高，注射器的销售量预计也会增加。主要注射器製造商也在提高产能，以应对疫苗需求的增加。

主要企业提供的产品

  • 预填充ApiJect 注射器，Apiject：预填充 ApiJect 注射器由 Apiject 提供。
  • BD EffivaxTM 玻璃预充式註射器，Becton，Dickinson and Company：着名的医疗技术提供者BD 开发了下一代玻璃预充式註射器，对可加工性、外观、耐污性和完整性提出了新的、更严格的要求。公牛注射器（PFS）。该 PFS 为疫苗接种 PFS 的性能树立了新的基准。为了满足疫苗生产复杂且不断变化的需求，与顶级製药公司合作创建了创新的 BD Efivax™ 玻璃预灌封注射器。

从材料来看，聚丙烯领域成长显着。

製药业已获得主要市场占有率，预计在预测期内也将主导市场。领先的药品製造商使用最先进的灭菌技术来防止疏忽和污染。吹灌封（BFS）技术提供安全、无菌的包装，已成为药品包装的流行方法。由于医疗保健行业对无菌包装的需求不断增长，领先公司正在使用采用这种吹灌封 (BFS) 技术的注射器。注射器在医疗保健中用于降低污染和剂量不准确的风险。此外，消除重复使用的可能性和防止交叉感染也是推动市场成长的主要因素。

欧洲地区预计将占据 BFS 注射器市场的主要份额：

预计欧洲市场在预测期内将大幅扩张。欧洲是药品製造商的顶级地区。欧洲市场预计将保持其作为 BSF 注射器製造商主要市场的地位。药品包装行业的主要参与者位于欧洲市场，并且更喜欢使用吹灌封技术进行注射剂灭菌，这一事实进一步强调了这一点。欧洲公司继续优先考虑注射包装，这推动了市场的爆炸性扩张。对管瓶、瓶子、安瓿和预填充式注射器等先进无菌包装的需求正在推动製药业越来越多地使用吹灌-封 (BFS) 技术。

主要进展

  • 知名医疗设备供应商 BD 的下一代玻璃预充式註射器 (PFS) 将于 2022 年 9 月发布，其在加工性能、外观、抗污染性和完整性方面均具有新增强的规格。该 PFS 为免疫 PFS 领域设定了新的性能标准。革命性的 BD Efivax™ 玻璃预充式註射器是与领先的製药公司合作开发的，以满足疫苗生产复杂且不断变化的要求。
  • Becton Dickinson & Company 宣布有意于 2021 年 11 月在西班牙投资新製造工厂。此举可能让该公司提高预充式註射器的生产能力。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析

第五章 BFS 注射器市场：按容量

  • 介绍
  • 0.5～1ml
  • 1～3ml
  • 3ml以上

第六章 BFS 注射器市场：依材料分类

  • 介绍
  • 聚丙烯（PP）
  • 聚氯乙烯（PVC）
  • 其他的

第 7 章 BFS 注射器市场：依最终使用者分类

  • 介绍
  • 製药/医疗保健
  • 个人护理和化妆品
  • 其他的

第八章 BFS 注射器市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 台湾
    • 泰国
    • 印尼
    • 其他的

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 供应商竞争力矩阵

第十章 公司简介

  • BREVETTI ANGELA Srl
  • Recipharm AB
  • The Ritedose Corporation
  • Amanta Healthcare
  • ApiJect Systems, Corp.
  • SIFI SpA
  • LyondellBasell Industries Holdings BV
简介目录
Product Code: KSI061616092

The BFS syringe market was valued at US$406.801 million in 2022.

The healthcare and cosmetics industries' rising need for BFS syringes is anticipated to fuel market expansion. The market demand is being driven by the choice of modern pharmaceutical packaging types and unit dosage packaging. Pharmaceutical businesses utilize prefilled syringes with blow-fill seal (BFS) technology. Throughout the projection period, a considerable increase in the market for BFS syringes is anticipated as a result of this. Aseptic packaging companies are increasingly using the sterilizing technique known as blow-fill-seal (BFS) for packaging and automated processes. The BFS technology has received FDA (Food and Drug Administration) certification for use in the production of pharmaceutical and healthcare products employing an improved aseptic processing technique which has created favorable market dynamics for expansion of the BFS syringe market. The demand in the market is also anticipated to be fueled by the usage of these syringes for cosmetics items in serum applications and other skincare products.

Introduction:

To offer parental preparation with very little human involvement, BFS technology has recently received great application in the pharmaceutical business. Several regulating organizations, including the US Food and Drug Administration (FDA), view this technique as a preferable approach for aseptic filling of parental preparation. Pharmaceutical packaging companies take into account several benefits of BFS syringes, including their cheap operating costs, flexible package designs, high levels of sterility, low labour demand, and small component inventories. The technology was created in Europe, where it is in high demand, followed by North America. The method is commonly used in the pharmaceutical industry to fill the parental preparation with fairly little human interference. Additionally, it is used to fill eye drops, inhalation devices, intravenous fluids, and other parent preparations. The healthcare sector's emphasis on efficiency and dose precision has sparked advancements in syringe technology. The packaging and use of syringes are changing with the introduction of blow-fill-seal (BFS) syringes. Leading syringe producers are now progressively migrating to BFS technology, which is regarded as a superior technique for aseptically filling parental preparation by several regulatory organizations which has consequently positively influenced market growth.

Drivers:

  • Rise in demand for aseptic packing is fueling market growth: With the introduction of automation in the packing business, BFS syringes provide a sterile solution and meet the demand for aseptic conditions. In terms of the number of clean items packed per minute, aseptic packaging using BFS syringe technology offers high precision which eventually fuels market growth.
  • Growth of the pharma industry is propelling market demand: The exponential growth in the pharma sector is a prime reason for boosting market growth. Leading pharmaceutical producers utilize cutting-edge sterilizing processes to minimize operator interaction and the possibility of contamination while packing liquid pharmaceuticals. It is a desirable technique for medicine packaging because it provides flexible diversity in packaging design, cost-effectiveness, sterility, and low component inventory.
  • BFS syringes reduce the chance of contamination hence creating market demand: Using automated BFS technology, syringes are manufactured, filled, and sealed all in one step. As a result, it reduces the chance of contamination and is therefore widely accepted among healthcare professionals.
  • These syringes do not require refrigeration for their storage which consequently reduces prices: For the aseptic packing of respiratory, ophthalmic, oral, and pre-filled syringes, and injectable pharmaceuticals, a BFS syringe is often used. These products are handy for consumers and cost-effective for vendors because they don't require refrigeration and therefore are economical.
  • Growing demand for vaccines from emerging economies: The surge in demand for vaccines from emerging economies is a major factor for market development. Syringe sales are expected to increase as immunization rates rise in nations like India. The main maker of syringes has also increased their production capacity as a result of the increasing demand for vaccinations.

Products offered by key companies:

  • Prefilled ApiJect Injector, Apiject: Prefilled ApiJect Injector is offered by Apiject. It is a delivery device created to combine the advantages of prefilled syringes with the manufacturing effectiveness of multi-dose presentations.
  • BD EffivaxTM Glass Prefillable Syringe, Becton, Dickinson and Company: BD, a prominent provider of medical technology unveiled a next-generation glass pre-fillable syringe (PFS) with new and stricter requirements for processability, cosmetics, contamination, and integrity. This PFS establishes a new benchmark in performance for vaccination PFS. To fulfil the complicated and changing demands of vaccine manufacture, the innovative BD EffivaxTM Glass Prefillable Syringe was created in partnership with top pharmaceutical firms.

The prominent growth in the Polypropylene sector under the material type segment

The pharmaceutical sector captured the major market share and is predicted to dominate the market over the forecast period. Leading pharmaceutical manufacturers prevent oversights and contamination by using cutting-edge sterilization technologies. Blow-fill-seal (BFS) technology provides safe and sterile packaging, making it a popular method for medicine packaging. Leading companies use these syringes utilizing the blow-fill-seal (BFS) technology in response to the growing need for aseptic packaging in the healthcare industry. Syringes are used in healthcare to lessen the danger of contamination and dose inaccuracy. Additionally, it eliminates the chance of reuse, preventing cross-infection which as a result is a major factor driving the market growth.

European region is expected to hold a significant share of the BFS syringe market:

The European market is poised to expand significantly over the projection period. Europe is a top-tier region concerning pharmaceutical producers. The market players located in the European market are extensively involved in the export of pharma products The European market is forecasted to sustain its position as a top market for BSF syringe manufacturers. Pharmaceutical packaging industry giants have established bases in the European market, and they have a preference for blow-fill-seal technology to sterilize injectables, which serves to emphasize this even more. European-based businesses have continued to prioritize injectable packaging, which is fueling the market's explosive expansion. The demand for sophisticated aseptic packaging, such as vials, bottles, ampoules, and pre-filled syringes, is driving an increase in the use of blow-fill-seal (BFS) technology in the pharmaceutical industry.

Key developments:

  • A next-generation glass pre-fillable syringe (PFS) from BD, a well-known supplier of medical equipment, was introduced with new and tighter specifications for processability, cosmetics, contamination, and integrity in September 2022. This PFS sets a new standard for performance in the field of immunization PFS. In collaboration with leading pharmaceutical companies, the ground-breaking BD EffivaxTM Glass Prefillable Syringe was developed to meet the complex and ever-changing requirements of vaccine manufacturing.
  • Becton, Dickinson, and Company declared their intention to invest in a new manufacturing facility in Spain in November 2021. The company may be able to increase its capacity for pre-fillable syringe production as a result of this action.

SEGMENTS:

BY CAPACITY

  • 0.5-1 ml
  • 1-3 ml
  • Above 3 ml

BY MATERIAL

  • Polypropylene (PP)
  • Polyvinyl Chloride (PVC)
  • Others

BY END-USER

  • Pharmaceutical and Healthcare
  • Personal Care and Cosmetics
  • Others

BY GEOGRAPHY

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. BFS SYRINGE MARKET, BY CAPACITY

  • 5.1. Introduction
  • 5.2. 0.5-1 ml
  • 5.3. 1-3 ml
  • 5.4. Above 3 ml

6. BFS SYRINGE MARKET, BY MATERIAL

  • 6.1. Introduction
  • 6.2. Polypropylene (PP)
  • 6.3. Polyvinyl Chloride (PVC)
  • 6.4. Others

7. BFS SYRINGE MARKET, BY END-USERS

  • 7.1. Introduction
  • 7.2. Pharmaceutical and Healthcare
  • 7.3. Personal Care and Cosmetics
  • 7.4. Others

8. BFS SYRINGE MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. The Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

  • 10.1. BREVETTI ANGELA S.r.l.
  • 10.2. Recipharm AB
  • 10.3. The Ritedose Corporation
  • 10.4. Amanta Healthcare
  • 10.5. ApiJect Systems, Corp.
  • 10.6. SIFI S.p.A
  • 10.7. LyondellBasell Industries Holdings B.V.

Not an exhaustive list